The future direction of Federal Reserve interest rate policy as well as opportunities tied to artificial intelligence remain hot topics among investors.
Researchers found improved outcomes for PT-Cy using a composite study endpoint of GVHD-free and relapse-free survival, but the regimens had similar overall survival and relapse-free survival outcomes.
Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders and Researchers finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Adaptive Biotech product 'clonoSEQ' is the first MRD test cleared by FDA for multiple myeloma, CLL, and B-ALL. See why investors should consider adding ADPT stock to their portfolio.